COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,693 Articles (22,913 medRxiv, 8,780 bioRxiv)

Most recent first Previous |  Page 2566: Articles 25651-25660  | Next

Alpha-1 antitrypsin inhibits SARS-CoV-2 infection
Wettstein, L., Conzelmann, C., Mueller, J. A., Weil, T., Gross, R., Hirschenberger, M., Seidel, A., Klute, S., Prelli-Bozzo, c., Zech, F., Preising, N., Fois, G., Lochbaum, R., Knaff, P., Mailaender, V., Staendker, L., Thal, D., Schumann, C., Stenger, S., Sparrer, K., Kleger, A., Lochnit, G., Kirchhoff, F., Frick, M., Muench, J.
10.1101/2020.07.02.183764 — Posted: 2020-07-02
Development of a Synthetic Poxvirus-Based SARS-CoV-2 Vaccine
Chiuppesi, F., Werner, M. S., Contreras, H., Nguyen, H. V., Martinez, J., Park, S., Nguyen, J., Kha, M., Iniguez, A., Zhou, Q., Kaltcheva, T., Levytskyy, R., Ebelt, N. D., Kang, T. H., Wu, X., Rogers, T., Manuel, E. R., Shostak, Y., Diamond, D. J., Wussow, F.
10.1101/2020.07.01.183236 — Posted: 2020-07-02
Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections
Benard, A., Jacobsen, A., Brunner, M., Krautz, C., Klosch, B., Swierzy, I., Naschberger, E., Birkholz, T., Castellanos, I., Trufa, D., Sirbu, H., Vetter, M., Kremer, A. E., Hildner, K., Hecker, A., Edinger, F., Tenbusch, M., Richter, E., Streeck, H., Berger, M. M., Brenner, T., Weigand, M. A., Swirski, F. K., Schett, G., Grutzmann, R., Weber, G. F.
10.1101/2020.07.02.184093 — Posted: 2020-07-02
Association between neutralizing antibodies to SARS-CoV-2 and commercial serological assays
Tang, M. S., Case, J. B., Franks, C. E., Chen, R. E., Anderson, N. W., Henderson, J. P., Diamond, M. S., Gronowski, A. M., Farnsworth, C. W.
10.1101/2020.07.01.182220 — Posted: 2020-07-02
Using iCn3D and the World Wide Web for structure-based collaborative research: Analyzing molecular interactions at the root of COVID-19
Youkharibache, P., Cachau, R. E., Wang, J., Madej, T.
10.1101/2020.07.01.182964 — Posted: 2020-07-02
6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro protease activities
Swaim, C. D., Perng, Y.-C., Zhao, X., Canadeo, L. A., Harastani, H. H., Darling, T. L., Boon, A. C. M., Lenschow, D. J., Huibregtse, J. M.
10.1101/2020.07.01.183020 — Posted: 2020-07-02
Hidden genomic diversity of SARS-CoV-2: implications for qRT-PCR diagnostics and transmission
Sapoval, N., Mahmoud, M., Jochum, M. D., Liu, Y., Elworth, R. A. L., Wang, Q., Albin, D., Ogilvie, H., Lee, M. D., Villapol, S., Hernandez, K., Maljkovic Berry, I., Foox, J., Beheshti, A., Ternus, K., Aagaard, K. M., Posada, D., Mason, C., Sedlazeck, F. J., Treangen, T. J.
10.1101/2020.07.02.184481 — Posted: 2020-07-02
Routine measurement of serum procalcitonin allows antibiotics to be safely withheld in patients admitted to hospital with SARS-CoV-2 infection.
Williams, E. J., Mair, L., de Silva, T. I., Green, D. J., House, P., Cawthron, K., Gillies, C., Wigfull, J., Parsons, H., Partridge, D. G.
10.1101/2020.06.29.20136572 — Posted: 2020-07-02
Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and correlation to tissue damage
Deinhardt-Emmer, S., Wittschieber, D., Sanft, J., Kleemann, S., Elschner, S., Haupt, K. F., Vau, V., Häring, C., Rödel, J., Henke, A., Ehrhardt, C., Bauer, M., Philipp, M., Gassler, N., Nietzsche, S., Löffler, B., Mall, G.
10.1101/2020.07.01.182550 — Posted: 2020-07-02
Community vulnerability to epidemics in Nepal: A high-resolution spatial assessment amidst COVID-19 pandemic
Khanal, L., Paudel, B. K., Acharya, B. K.
10.1101/2020.07.01.20144113 — Posted: 2020-07-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).